Neuroleptic malignant syndrome and hypothyroidism.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2380733.
- Also identified by PMC identifier 1014214.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two patients with primary hypothyroidism who developed neuroleptic malignant syndrome (NMS) are described. Thyroid disease might predispose to NMS by altering brain dopamine metabolism.
Medical subject headings
- Hypothyroidism
- Neuroleptic Malignant Syndrome
- Obsessive-Compulsive Disorder
- Paranoid Disorders
- Thioridazine